Jethro Marks
Director/Board Member at DRONESHIELD LIMITED
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter James | M | 74 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | 8 years |
Oleg Vornik | M | - | 9 years | |
Carla Balanco | F | - | 6 years | |
Matthew B. Lehman | M | 47 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
Robert Clisdell | M | - |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | 4 years |
Angus Bean | M | - | 8 years | |
Matt McCrann | M | - | - | |
Paul Cenoz | M | - | 1 years | |
Andrew Bursill | M | 53 |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
Stuart K. Williams | M | - |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | - |
Tom Branstetter | M | - | 5 years | |
Hedley Boyd-Moss | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Donald M. Maffei | M | - | - | |
Belinda Cleminson | F | - | - | |
James Gatley | M | - | 2 years | |
Thaïs Rochard | F | - | 1 years | |
Lyle Halliday | M | - | 3 years | |
Red McClintock | M | - | - | |
Katherine Stapels | F | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
Australia | 19 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jethro Marks
- Personal Network